Last reviewed · How we verify
Community-acquired pneumonia
Approved treatments
- Cefpodoxime Proxetil · Pfizer
- Test formulation (Treatment A) · Pfizer
- Piperacillin And Tazobactam · Pfizer
Piperacillin and tazobactam is an antibacterial drug combining a penicillin with a beta-lactamase inhibitor. - Taigexyn
Taigexyn works by inhibiting bacterial DNA replication and transcription. - Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Zithromax · Pfizer Inc.
Azithromycin is a macrolide antibacterial drug.
Clinical guidelines
- FDA label — 1L
Azithromycin is indicated for community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in patients appropriate for oral therapy. - FDA label — 1L
Linezolid is indicated for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, including cases with concurrent bacteremia, or Staphylococcus aureus (methicillin-susceptible isolates only).
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Community-acquired pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Community-acquired pneumonia treatment landscape brief
- Community-acquired pneumonia treatment updates RSS
Frequently asked questions about Community-acquired pneumonia
What drugs treat Community-acquired pneumonia?
Tracked treatments include Cefpodoxime Proxetil, Test formulation (Treatment A), Piperacillin And Tazobactam, Taigexyn, Invanz, Zithromax.
What is the treatment for Community-acquired pneumonia?
Standard treatment for Community-acquired pneumonia includes Cefpodoxime Proxetil, Test formulation (Treatment A), Piperacillin And Tazobactam, Taigexyn, Invanz. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Community-acquired pneumonia?
FDA label publishes guidelines for Community-acquired pneumonia. 2 guideline references tracked.
Related
- Treatment landscape: Community-acquired pneumonia patent cliff · Community-acquired pneumonia CI report
- Treatment: Cefpodoxime Proxetil · Pfizer
- Treatment: Test formulation (Treatment A) · Pfizer
- Treatment: Piperacillin And Tazobactam · Pfizer
- Treatment: Taigexyn
- Treatment: Invanz · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing